General Information

Welcome to (PPGBIOTEC) at Ufes

  • Establish and validate new epidemiological and laboratory diagnostic markers, including genomic, transcriptomic and epigenetic studies in several genetic, metabolic, infectious and neoplastic diseases. Biochemical, serological and molecular characterization of microorganisms; Evaluation of antimicrobial properties in extracts of plant and animal origin; Identification of antigens for use in vaccines and diagnosis; Molecular markers of infections and neoplasias. Development of new therapies for ischemic diseases through the use of stem cells and cell growth factors in experimental models, as well as the reconstruction of in vitro organs for transplantation.

  • Computer techniques applied to the processing of biological signals (muscular signals - sEMG, potential cortico-retina: electrooculographic signals - EOG, brain signals - EEG and temperature signals by dilation of the blood vessels of the skin). Upper limb myoelectric prosthesis (sEMG); Rehabilitation robotics; Robotic walker driven by motor intention (EEG signals); Robotic telepresence (EEG signals); Robot interaction with children with autism (EEG and facial flushing). Development of new routes of synthesis of metallic nanoparticles for biomedical application as diagnostic sensors for organic molecules, drug loading and antigens, as well as antibacterial treatment.

  • Prospecting, identification, development and applications of genes and biological functions that promote tolerance to abiotic and biotic stresses and elimination of phytopathogens and contaminants in food. Identification, structural and functional characterization of new molecules to increase the production capacity of biologically based products with low environmental impact. Adaptation and development of bioinformatics in support of synthetic biology, biosimulation, bioprospecting and advanced manufacturing based on biologically based knowledge.

  • Determination of population genetic variations in human diseases. Evaluation of the applicability of biomarkers of prognosis and biological tumor behavior in malignant neoplasias, integrating the basic research to clinical research applied to the resolution of current clinical problems. Use of clinical, laboratory, anatomopathological and imaging resources for the knowledge of the pathophysiological mechanisms and therapeutics of chronic, neoplastic and infectious diseases. Analysis of gene expression, using varied and innovative tools, with the purpose of implementing processes and services that can be applied in the public health system. Biochemical and immunopathological changes due to contact or exposure to chemical and biological agents. The study of this line addresses the use of new technologies, such as high performance sequencing, use of DNA and RNA hybrids probes, immunohistochemistry, flow cytometry, time PCR Real, among others, to investigate genomic, proteomic and metabolomic alterations related to the various clinical manifestations of human diseases.

  • Integrative analysis of the databases of advanced biology (interaction between genes, protein and metabolism) strengthening the systems biology focused on promoting productivity and sustainability in the biotechnological sectors of agribusiness. Domain of engineering processes of the genetic function and its use in the modification and modulation of biological systems. Molecular diagnosis of phytopathogens.

  • Advancing the frontier of scientific and technological knowledge to increase the competitiveness and dynamism of biotechnology applied to agribusiness, highlighting the application of new technologies, methods and processes in the exploration of functions and new uses of biological resources, with emphasis on the generation of new innovation. Invest in tools and processes that can support predictions about the technological needs and the future demand for goods and services in the area of ​​biotechnology.

Biotechnology involves the use of microbiological processes, living organisms, and bio-systems in order to create practices and products that improve the quality of human life. From the food and medicine we buy to the ways we clean up the environment, biotechnology affects many facets of our daily lives.
The main goals of the Postgraduate Program in Biotechnology are to equip students with advanced scientific and technical knowledge to prepare them for work as innovators and entrepreneurs. The program fosters the development of biotechnological products and processes and the transfer of technology to the agribusiness and health industries. Since its accreditation by the Brazilian official agency in 2007, the program has formed specialized master’s and doctoral students to teach and carry out research in biotechnology thus promoting the expansion of scholarly work in the field.

Postgraduate Degrees

The program offers M.Sc. and PhD degrees in biotechnology. Holders of an M.Sc. and a PhD in biotechnology work in several key areas, including medicine, agriculture, food technology, biological engineering, biodegradation and education. With an M.Sc. or a PhD in biotechnology, a graduate is highly qualified to work in a management position at a number of public and private organizations. In addition, a PhD in biotechnology will foster students’ intellectual and professional growth in face of the challenges of higher education and research in the field.

M.Sc. in Biotechnology

The main entry requirement for MSc candidates is an undergraduate degree in bioscience, biotechnology or related science fields or their foreign equivalents, such as physical, life, health, or computer sciences.

** PhD in Biotechnology**

The minimum requirement for admission to the PhD program is an M.Sc. degree related to biotechnology research. Exceptionally, candidates who do not hold a master’s degree may be admitted to the PhD program through outstanding achievement in their undergraduate degree, as evidenced by reports on research and technology, publications in journals, patent registrations, etc.

The program is based in Vitória-ES, offering the course of PhD in Biotechnology since 2016 e the course of M.Sc. in Biotechnology since 2007 and has an academic qualification profile certified by CAPES, receiving 4 on its last evaluation.

The program already has 137 masters and 33 doctors and counts with 103 students regularly enrolled, being 38 in the masters and 65 in the doctorate.

Transparência Pública
Acesso à informação

© 2013 Universidade Federal do Espírito Santo. Todos os direitos reservados.
Av. Marechal Campos, 1468 - Maruípe, Vitória - ES | CEP 29043-900